Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$419M |
| 2 |
Truist Financial
TFC
|
+$351M |
| 3 |
Mastercard
MA
|
+$218M |
| 4 |
PPL
PPL Corp
PPL
|
+$193M |
| 5 |
Cognizant
CTSH
|
+$151M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$592M |
| 2 |
IBM
IBM
|
+$320M |
| 3 |
Wells Fargo
WFC
|
+$306M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$290M |
| 5 |
Walt Disney
DIS
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.49% |
| 2 | Financials | 13.79% |
| 3 | Healthcare | 13.31% |
| 4 | Consumer Discretionary | 10.06% |
| 5 | Industrials | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNCB
3301
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $681K | ﹤0.01% |
80,676
+20,896
| +35% | +$164K |
|
|
DSL
3302
DoubleLine Income Solutions Fund
DSL
$1.24B
| $680K | ﹤0.01% |
34,454
-4,800
| -12% | -$95.3K |
|
|
LGI
3303
Lazard Global Total Return & Income Fund
LGI
$242M
| $680K | ﹤0.01% |
+41,100
| New | +$646K |
|
3304
Virgin Galactic
SPCE
$475M
| $680K | ﹤0.01% |
+2,940
| New | +$574K |
|
3305
Mizuho Financial
MFG
$134B
| $678K | ﹤0.01% |
219,189
+44,535
| +25% | +$139K |
|
3306
Invesco Water Resources ETF
PHO
$2.06B
| $678K | ﹤0.01% |
17,556
-150
| -0.8% | -$5.56K |
|
3307
Legacy Housing
LEGH
$692M
| $676K | ﹤0.01% |
40,626
+26,503
| +188% | +$415K |
|
3308
VanEck Agribusiness ETF
MOO
$972M
| $673K | ﹤0.01% |
9,795
+100
| +1% | +$6.67K |
|
3309
AXT Inc
AXTI
$5.07B
| $671K | ﹤0.01% |
154,246
-44,858
| -23% | -$144K |
|
|
BSMO
3310
DELISTED
Invesco BulletShares 2024 Municipal Bond ETF
BSMO
| $670K | ﹤0.01% |
26,659
-13,341
| -33% | -$334K |
|
3311
MannKind Corp
MNKD
$1.2B
| $669K | ﹤0.01% |
518,737
+8,786
| +2% | +$11.2K |
|
3312
Cadiz
CDZI
$295M
| $667K | ﹤0.01% |
60,551
-10,025
| -14% | -$116K |
|
3313
SSR Mining
SSRM
$6.49B
| $665K | ﹤0.01% |
34,503
-12,952
| -27% | -$202K |
|
3314
B2Gold
BTG
$6.7B
| $662K | ﹤0.01% |
165,208
+9,360
| +6% | +$33K |
|
3315
First Bank
FRBA
$471M
| $659K | ﹤0.01% |
59,647
-21,143
| -26% | -$229K |
|
3316
Syndax Pharmaceuticals
SNDX
$1.7B
| $658K | ﹤0.01% |
74,987
+2,642
| +4% | +$19.4K |
|
3317
Boston Omaha
BOC
$431M
| $656K | ﹤0.01% |
31,208
-277
| -0.9% | -$5.81K |
|
|
CEN
3318
DELISTED
Center Coast Brookfield MLP & Energy Infrastructure Fund
CEN
| $656K | ﹤0.01% |
10,335
+6,618
| +178% | +$425K |
|
3319
FS KKR Capital
FSK
$3.49B
| $653K | ﹤0.01% |
26,609
+8,490
| +47% | +$203K |
|
3320
Abeona Therapeutics
ABEO
$361M
| $652K | ﹤0.01% |
7,991
+2,114
| +36% | +$149K |
|
3321
ALPS O'Shares US Small-Cap Quality Dividend ETF
OUSM
$888M
| $651K | ﹤0.01% |
22,000
| – | – |
|
3322
iShares MSCI World ETF
URTH
$8.4B
| $650K | ﹤0.01% |
+6,585
| New | +$627K |
|
|
TCS
3323
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $650K | ﹤0.01% |
10,267
+3,067
| +43% | +$194K |
|
3324
WBI BullBear Value 3000 ETF
WBIF
$23.8M
| $648K | ﹤0.01% |
23,286
+1,182
| +5% | +$32.1K |
|
3325
ADMA Biologics
ADMA
$2.11B
| $647K | ﹤0.01% |
161,653
+27,901
| +21% | +$122K |
|
Similar funds
Bank of New York Mellon's Q4 2019 Portfolio in Review
As of Q4 2019, Bank of New York Mellon held 4,341 positions worth $388B, up 6.4% from $364B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Bank of New York Mellon's Q4 2019 filing shows 131 new, 1,843 increased, 1,854 reduced and 165 closed positions. Its largest new stake was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M. The largest sale was Celgene Corp, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2019 buy was State Street SPDR Bloomberg Emerging Markets Local Bond ETF: 1,648,268 shares worth $46M.
- Bank of New York Mellon added most to Bristol-Myers Squibb in Q4 2019, an estimated $419M increase.
- Bank of New York Mellon's biggest Q4 2019 reduction was IBM, cutting an estimated $320M.
- Bank of New York Mellon fully exited Celgene Corp in Q4 2019, selling an estimated $592M.
- Bank of New York Mellon's ten largest holdings make up 16% of its $388B portfolio in Q4 2019.
- Bank of New York Mellon opened 131 new positions and closed 165 in Q4 2019.
- Bank of New York Mellon's portfolio value rose 6.4% quarter-over-quarter to $388B.
Based on Bank of New York Mellon's 13F filing for Q4 2019, filed 14 Feb 2020.